[Clinical evaluation of RT-PCR method for detection of HCV-RNA--with special reference to Amplicor HCV]. 1997

C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
Central Clinical Laboratories, Shinshu University Hospital, Matsumoto.

Detection of the viral genome in serum is the most reliable way to analyze HCV viremia. In the present study, we evaluated the availability of a new detection kit for HCV-RNA, Amplicor HCV, which is based on the RT-PCR microplate hybridization protocol. The procedure of Amplicor HCV is simple, unlike the conventional RT-nested-PCR method. Although Amplicor HCV assay exhibited the lower sensitivity than the the conventional RT-nested-PCR method (10 x for HCV type 1a, 1b and 2b; 10(3) x for type 2a), Amplicor HCV assay could detect the HCV-RNA in all HCV-RNA positive cases by conventional RT-nested PCR method, except for one case who contained low concentration of HCV-RNA (10 copies/ml). The coincidence rate was 99.2% in 120 clinical samples between two assays. Amplicor HCV assay, moreover, could efficiently evaluate the viremia regardless of anti-HCV-2 antibody titer. This assay was useful for monitoring the effect of interferon therapy during and after administration. These results suggest that Amplicor HCV has an excellent availability for the clinical laboratories.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
February 1998, Rinsho byori. The Japanese journal of clinical pathology,
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
July 1995, Cellular and molecular biology (Noisy-le-Grand, France),
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
May 1999, Journal of medical virology,
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
November 2008, Japanese journal of infectious diseases,
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
February 2000, Clinical chemistry and laboratory medicine,
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
January 1999, Methods in molecular medicine,
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
January 1999, Methods in molecular medicine,
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
January 1999, Methods in molecular medicine,
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
February 2008, Rinsho byori. The Japanese journal of clinical pathology,
C Furuwatari, and K Suzuki, and A Matsumoto, and M Kobayashi, and K Kiyosawa, and E Hidaka, and I Ueno, and Y Ogiso, and K Furihata, and T Katsuyama
January 1996, Vox sanguinis,
Copied contents to your clipboard!